Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 2/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | MET | P08581 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | STAT1 | P42224 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NT5E | P21589 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25548278 | 0.99 | ALOX5 (0.35) | ALOX5ABCG2GRM5PARP1MET | |
| SCHEMBL25548283 | 0.96 | ABCG2 (0.38) | ALOX5ABCG2GRM5PARP1MET | |
| SCHEMBL25609264 | 0.96 | ALOX5 (0.37) | ALOX5ABCG2GRM5PARP1MET | |
| SCHEMBL25548277 | 0.95 | ALOX5 (0.38) | ALOX5ABCG2GRM5PARP1MET | |
| SCHEMBL25609263 | 0.94 | ABCG2 (0.40) | ALOX5ABCG2GRM5PARP1KDM4E | |
| SCHEMBL25548270 | 0.94 | ALOX5 (0.39) | ALOX5ABCG2GRM5PARP1MET | |
| SCHEMBL25548276 | 0.93 | ABCG2 (0.40) | ALOX5ABCG2GRM5PARP1KDM4E | |
| SCHEMBL25548141 | 0.93 | ALOX5 (0.39) | ALOX5PARP1METKDM4EMEN1 | |
| SCHEMBL25548281 | 0.93 | ALOX5 (0.39) | ALOX5PARP1METKDM4EMEN1 | |
| SCHEMBL25548286 | 0.93 | ALOX5 (0.39) | ALOX5PARP1METKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167089-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20230167089-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167089-A1 | ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF | PIEZO1, VCL, VDAC3 | ALOX5 977/4885ABCG2 739/4885GRM5 1758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.